Articles About vivus
-
May 15, 2013Is Vivus a Buy at These Prices?
Vivus is a biopharmaceutical company that is attacking issues negatively affecting many American people. The stock has not done too well lately but may be currently stabilizing from a recent rise in selling.
-
May 14, 2013Analysts: Market Is Beginning to Recognize Tesla and 3 Other Research Notes to Check Out
Here's what analysts are telling investors today...
-
May 13, 2013Starbucks Looks to Myanmar, Delta and United Grapple With New Flu, and 2 Other Hot Stocks
Here are some hot stocks seeing market action today...
-
May 06, 2013This Is Why Doctors Love Apple
Did Apple’s iPhone and iPad unintentionally become the healthcare industry’s new favorite tools?
-
May 01, 20133 Healthcare Stock Stories For Tuesday Portfolio Wellness
Your Cheat Sheet to the top healthcare business news...
-
April 25, 2013Is Vivus Undervalued?
Vivus researches, develops, and manufactures pharmaceutical products that may have a very positive impact on the lives of many consumers worldwide. The stock has recently broken above key levels but has returned to test these price levels once again...
-
April 19, 2013Blackstone Bids Dell Farewell and 3 Other Hot Stocks
Here are some hot stocks seeing movement in the markets today...
-
April 17, 2013
3 Healthcare Stock Stories for Wednesday Investment Wellness
Here are a few top Healthcare stock stories for the afternoon: 3 Healthcare Stock Stories for Wednesday Investment Wellness
-
February 22, 2013
4 Healthcare Stock Stories Prescribed for Weekend Reading
Analysis of Top healthcare Business News: 4 Healthcare Stock Stories Prescribed for Weekend Reading
-
February 01, 2013Merck’s Sales Tumble and Pfizer’s Zoetis Goes Public: Healthcare Recap
Shares of Vivus, Zoetis, and Merck were all on the move Friday...
-
January 18, 2013Vivus Plunges on Downgrade, Johnson & Johnson Ties Up Loose Ends, Pfizer Initiates a Spin-Off
Shares of Johnson & Johnson, Pfizer, and Vivus are all on the move on Friday...
-
January 18, 2013Capital One Initiated at Outperform and 3 Initiated Stocks to Track
Take a closer look at the new ratings and price targets...
-
January 17, 2013
4 Healthcare Stock Stories for a Thursday Cure
Your Cheat Sheet to the top healthcare business news...
-
January 17, 2013Vivus’s Weightloss Drug is a Flop and 2 Hot Healthcare Stocks to Watch
Shares of UnitedHealth, Intuitive Surgical, and Vivus are all on the move on Wednesday...
-
January 07, 2013Will Vivus’s Weight-Loss Drug Fall Flat?
Qsymia sales only generated $41,000 in the company’s third quarter, representing 656 filled prescriptions. But on Monday, Vivus reported that sales of its main product rose close to 68 percent in the month ended December 21, which was well above analysts' expectations...
Wall St. Cheat Sheet has been featured in these fine media outlets:
